FAIRsharing record for: COVID-19 SeroHub

This FAIRsharing record describes: The COVID-19 Seroprevalence Studies Hub, known as COVID-19 SeroHub, is an online dashboard intended to help researchers and policymakers monitor studies of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) seroprevalence in the United States. These types of studies use blood tests to identify the proportion of people in the population who possess antibodies to SARS-CoV-2.
COVID-19 SeroHub is a collaboration of the Centers for Disease Control and Prevention, the National Cancer Institute and National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.